"After another difficult year, there are signs that biotech is recovering into 2024," the investment bank says, citing the prospect of interest rate cuts.
Piper Sandler sees potential turnaround for Biotech sector in 2024, identifies thee top stocks; Arrowhead, Legend Biotech & Alnylam Pharmaceuticals.